Mostrando resultados 8 a 18 de 18
< Anterior
Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
openAccess | | 2020 | Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study | Dimopoulos, Meletios A.; Lonial, Sagar; White, Darrell; Moreau, Philippe; Weisel, Katja C.; San-Miguel, Jesús; Shpilberg, Ofer; Grosicki, Sebastian; Špička, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Spencer, Andrew; Oakervee, Heather; Orlowski, R. Z.; Taniwaki, Masafumi; Röllig, Christoph; Einsele, Hermann; Matsumoto, Morio; Wu, Ka Lung; Anderson, Kenneth; Jou, Ying-Ming; Ganetsky, Alex; Singhal, Anil K.; Richardson, Paul G. | artículo |
closedAccess | | 2011 | Future Directions of Next-Generation Novel Therapies, Combination Approaches, and the Development of Personalized Medicine in Myeloma | Mitsiades, C. S.; San Miguel, Jesús F. CSIC ORCID; Richardson, Paul G. | artículo |
closedAccess | | 2012 | Management of treatment-emergent peripheral neuropathy in multiple myeloma | Richardson, Paul G.; Lahuerta, Juan José; Mateos, Maria Victoria; Bladé, Joan; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | feb-2022 | Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study | Schjesvold, Fredrik; Dimopoulos, Meletios A.; Delimpasi, Sosana; Robak, Pawel; Coriu, Daniel; Legiec, Wojciech; Pour, Ludek; Špička, Ivan; Masszi, Tamas; Doronin, Vadim; Minařík, Jiří; Salogub, Galina; Alekseeva, Yulia; Lazzaro, Antonio; Maisnar, Vladimir; Mikala, Gábor; Rosiñol, Laura; Liberati, Anna Marina; Symeonidis, Argiris; Moody, Victoria; Thuresson, Marcus; Byrne, Catriona; Harmenberg, Johan; Bakker, Nicolaas; Hajek, Roman; Mateos, Maria Victoria; Richardson, Paul G.; Sonneveld, Pieter; OCEAN (OP-103) Investigators | artículo |
closedAccess | | 2022 | Melphalan flufenamide for relapsed/ refractory multiple myeloma | Nadeem, O.; Mateos, Maria Victoria; Efebera, Y. A.; Paner, A.; Larocca, Alessandra; Rodríguez-Otero, Paula; Leleu, Xavier; Richardson, Paul G. | artículo |
openAccess | | 2016 | Myeloma cell dynamics in response to Treatment supports a model of hierarchical differentiation and clonal evolution | Tang, Min; Zhao, Rui; Velde, Helgi van de; Tross, Jennifer G.; Mitsiades, C. S.; Viselli, Suzanne; Neuwirth, Rachel; Esseltine, Dixie-Lee; Anderson, Kenneth; Ghobrial, Irene M.; San Miguel, Jesús F. CSIC ORCID; Richardson, Paul G.; Tomasson, Michael H.; Michor, Franziska | artículo |
closedAccess | | 2014 | New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG) | Ocio, Enrique M. CSIC ORCID ; Richardson, Paul G.; Rajkumar, S. Vincent; Palumbo, Antonio; Mateos, Maria Victoria; Orlowski, R. Z.; Kumar, Sumit; Dimopoulos, Meletios A.; Merlini, Giampolo; Lahuerta, Juan José; Lonial, Sagar; Moreau, Philippe; Ludwig, Heinz; San Miguel, Jesús F. CSIC ORCID | artículo |
openAccess | | 2013 | Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma | San Miguel, Jesús F. CSIC ORCID; Dimopoulos, Meletios A.; Palumbo, Antonio; Delforge, Michel; Mateos, Maria Victoria; Richardson, Paul G. | artículo |
closedAccess | | 2012 | Proteasome inhibitors in multiple myeloma: 10 years later | Moreau, Philippe; Richardson, Paul G.; Cavo, Michele; Orlowski, R. Z.; San Miguel, Jesús F. CSIC ORCID; Palumbo, Antonio; Harousseau, Jean-Luc | artículo |
closedAccess | | 2009 | Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline | Richardson, Paul G.; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | 2011 | Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib–melphalan–prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study | Dimopoulos, Meletios A.; Mateos, Maria Victoria; Richardson, Paul G.; San Miguel, Jesús F. CSIC ORCID | artículo |